期刊文献+

脾切除治疗移植相关血栓性微血管病导致血小板减少一例报告附文献复习 被引量:1

原文传递
导出
摘要 移植相关血栓性微血管病(TA—TMA)是指发生于造血干细胞移植(HSCT)后,以微血管病性溶血性贫血、消耗性血小板减少以及脏器功能不全为特征,包括血栓性血小板减少性紫癜和溶血尿毒症综合征在内的一组疾病的总称,首次报道于1980年。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第6期491-492,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献9

  • 1Powles RL, Clink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow trans- plantation. Lancet, 1980, 1:327-329.
  • 2Uderzo C, Bonanomi S, Busca A, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoi- eric stem cell transplantation. Transplantation, 2006, 82: 638- 644.
  • 3Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant, 1995, 15:247-253.
  • 4韩悦,吴德沛,阮长耿.造血干细胞移植相关的血栓性微血管病研究进展[J].中华血液学杂志,2007,28(8):574-576. 被引量:7
  • 5Shatry AM, Jones M, Levy RB. The effect of the spleen on com- partmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants. Stem Cells Dev, 2004, 13:51-62.
  • 6Grigg AP, Berean K, Shore T, et al. Pancytopenia due to hyper- splenism after allogeneic bone marrow transplantation. Bone Mar- row Transplant, 1992, 10 : 177-179.
  • 7Richard C, Rom6n I, Perez-Encinas M, et al. Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia. Leukemia, 1996, 10: 1615-1618.
  • 8Pamphilon DH, Cornish JM, Goodman S, et al. Successful second unrelated donor BMT in a child with juvenile chronic myeloid leu- kaemia: documentation of chimaerism using the polymerase chain reaction. Bone Marrow Transplant, 1993, 11 : 81-84.
  • 9Bostrom L, Ringd6n O, Jacobsen N, et al. A European multi- center study of chronic graft-versus-host disease. The role of cyto- megalovirus serology in recipients and donors--acute graft-versus- host disease, and splenectomy. Transplantation, 1990, 49 : 1100- 1105.

二级参考文献19

  • 1Powles RL, Clinck HM, Spence D, et al. Cyclosporine to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet, 1980, 1: 327-329.
  • 2Moake JL. Thrombotic microangiopathies. N Engl J Med, 2002, 347 : 589-600.
  • 3Peyvandi F, Siboni SM, Lambertenghi Deliliers D, et al. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of yon Willebrand factor after bone marrow transplantation. Br J Haematol, 2006, 134:187-195.
  • 4Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost, 2005, 31:691-699.
  • 5Daly AS, Xenocostas A, Lipton JH. Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant, 2002, 30:709-715.
  • 6Dlott JS, Danielson CF, Blue-Hnidy DE, et al. Drug-induced thrombotic thrombocytopenic purpura- hemolytic uremic syndrome: a concise reviewl Ther Apher Dial, 2004, 8 : 102-111.
  • 7Gerbitz A, Nickoloff B J, Olkiewicz K, et al. A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome. Transplantation, 2004, 78:494-502.
  • 8Zeigler Z, Kelton J, Moore J, et al. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura. Bone Marrow Transplant, 1999, 24:641-645.
  • 9Takatsuka H, Wakae T, Toda A, et al. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation. Clin Transplant, 2004, 18:547-551.
  • 10George JN, Li X, McMinn JR, et al. Thrombotic thrombocytopenic purpura- hemolytic uremic syndrome following allogeneic HPC transplantation : a diagnostic dilemma. Transfusion, 2004,44 : 294-304.

共引文献6

同被引文献9

  • 1SCULLY M,HUNT B J,BENJAMIN S,et al.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and otherthrombotic microangiopathies[J] .Br J Haematol,2012,158:323-335.
  • 2BATTS E D,LAZARUS H M.Diagnosis and treatment of transplantation-associated thrombotic microangiopathy:real progress or are we still waiting?[J] .Bone Marrow Transplant,2007,40:709-719.
  • 3LASKIN B L,GOEBEL J,DAVIES S M,et al.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT[J] .Bone Marrow Transplant,2011,46:682-689.
  • 4WILLEMS E,BARON F,SEIDEL L,et al.Comparison of thrombotic microangiopathy after allogeneic hematopoietic celltansplantation with high-dose or nonmyeloablatie conditioning[J] .Bone Marrow Transplant,2010,45:689-693.
  • 5CHOI C M,SCHMAIER A H,SNELL M R,et al.Thrombotic microangiopathy in haematopoietic stem cell transplantation:diagnosis and treatment[J] .Drugs,2009,69:183-198.
  • 6STAVROU E,LAZARUS H M.Thrombotic microangiopathy in haematopoietic cell tranplantation:an update[J] .Mediterr J Hematol Infect Dis,2010,2:e2010033.
  • 7KANAMORI H,MARUTA A,SASAKI S,et al.Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy[J] .Bone Marrow Transplant,1998,21:705-709.
  • 8KENNEDY G A,KEAREY N,BLEAKLEY S,et al.Transplantation-associated thrombotic microangiogpahy effect of concomitant GVHD on efficacy of therapeutic plasma exchange[J] .Bone Marrow Transplant,2010,45:699-704.
  • 9POGLIANI E M,PERSEGHIN P,PARMA M,et al.Defibrotide in recurrent thrombotic thrombocytopenic purpura[J] .Clin Appl Thromb Hemost,2000,6:69-70.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部